Stay updated on Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, signaling a new build of the page. This reflects an internal version update rather than a content change.
    Difference
    0.1%
    Check dated 2026-08-08T18:20:31.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page footer now shows the updated site revision number (v3.6.4), replacing the previous v3.6.3. This indicates a minor platform update that does not modify study content or functionality.
    Difference
    0.1%
    Check dated 2026-07-25T10:00:50.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.2 to v3.6.3, indicating a minor version update to the page rather than a content change.
    Difference
    0.1%
    Check dated 2026-07-03T21:50:18.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.6.0 to v3.6.2, indicating a small internal update to the page rendering or templates. No study content or user-visible information was altered.
    Difference
    0.1%
    Check dated 2026-06-27T00:21:43.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    New sections How to Read a Study Record, Common Questions, and How to Join a Study were added, and Hyun Cheol Chung and Yonsei University are now listed as the responsible party; the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    2%
    Check dated 2026-06-12T16:06:01.000Z thumbnail image
  9. Check
    85 days ago
    Change Detected
    Summary
    The page's footer revision label was updated from v3.5.4 to v3.5.5, indicating a new deployment or update to the site's interface. This appears to be a version-tracking or maintenance change rather than a modification to study details or content.
    Difference
    0.1%
    Check dated 2026-06-05T11:44:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.